About the Company
Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Myovant Sciences has one FDA-approved medicine, ORGOVYX™ (relugolix), for adult patients with advanced prostate cancer. Its lead product candidate, relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis. Myovant Sciences is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is its majority shareholder.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MYOV News
BioLight Life Sciences Ltd BOLT
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
MILLENNIUM PHARMACEUTICALS INC's Net Worth
Inc., and Myovant Sciences Ltd.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive ...
Camlin Fine Sciences Ltd (CAMLINFINE) Share Price
Camlin Fine Sciences Ltd share price was up by 0.50% from the previous closing price of ₹110.85. Who are peers of Camlin Fine Sciences Ltd? The peers of Camlin Fine Sciences Ltd are Pidilite ...
Suven Life Sciences Ltd (SUVEN) Share Price
Suven Life Sciences Ltd share price was up by 2.11% from the previous closing price of ₹99.45. Who are peers of Suven Life Sciences Ltd? The peers of Suven Life Sciences Ltd are Sun ...
WAVE Life Sciences Ltd WVE
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Roivant Sciences Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Wave Life Sciences Ltd. (NASDAQ:WVE) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Wave Life Sciences Ltd. (NASDAQ:WVE) defied analyst predictions to release its annual results, which were ahead of market expectations. Revenues beat expectations coming in atUS$113m, ahead of ...
AI + Y 2024 Series | Hosted by the Chemical Sciences Roundtable | AI + Limited Data
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Roivant Sciences (ROIV) Shares Cross Below 200 DMA
In trading on Monday, shares of Roivant Sciences Ltd (Symbol: ROIV) crossed below their 200 day moving average of $10.50, changing hands as low as $10.40 per share. Roivant Sciences Ltd shares are ...
Roivant Sciences Ltd. (ROIV) Q3 2023 Earnings Call Transcript
Hello, thank you for standing by. Welcome to Roivant Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there ...
Hindustan Bio Sciences Ltd. Share Price
Hindustan Bio Sciences Ltd. is a Public Limited Listed company incorporated on 13/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification ...
WVE Wave Life Sciences Ltd.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
Loading the latest forecasts...